Bright light in elderly subjects with nonseasonal major depressive disorder: a double blind randomised clinical trial using early morning bright blue light comparing dim red light treatment

Ritsaert Lieverse, Marjan M A Nielen, Dick J Veltman, Bernard M J Uitdehaag, Eus J W van Someren, Jan H Smit, Witte J G Hoogendijk, Ritsaert Lieverse, Marjan M A Nielen, Dick J Veltman, Bernard M J Uitdehaag, Eus J W van Someren, Jan H Smit, Witte J G Hoogendijk

Abstract

Background: Depression frequently occurs in the elderly. Its cause is largely unknown, but several studies point to disturbances of biological rhythmicity. In both normal aging, and depression, the functioning of the suprachiasmatic nucleus (SCN) is impaired, as evidenced by an increased prevalence of day-night rhythm perturbations, such as sleeping disorders. Moreover, the inhibitory SCN neurons on the hypothalamus-pituitary adrenocortical axis (HPA-axis) have decreased activity and HPA-activity is enhanced, when compared to non-depressed elderly. Using bright light therapy (BLT) the SCN can be stimulated. In addition, the beneficial effects of BLT on seasonal depression are well accepted. BLT is a potentially safe, nonexpensive and well accepted treatment option. But the current literature on BLT for depression is inconclusive.

Methods/design: This study aims to show whether BLT can reduce non-seasonal major depression in elderly patients. Randomized double blind placebo controlled trial in 126 subjects of 60 years and older with a diagnosis of major depressive disorder (MDD, DSM-IV/SCID-I). Subjects are recruited through referrals of psychiatric outpatient clinics and from case finding from databases of general practitioners and old-people homes in the Amsterdam region. After inclusion subjects are randomly allocated to the active (bright blue light) vs. placebo (dim red light) condition using two Philips Bright Light Energy boxes type HF 3304 per subject, from which the light bulbs have been covered with bright blue- or dim red light- permitting filters. Patients will be stratified by use of antidepressants. Prior to treatment a one-week period without light treatment will be used. At three time points several endocrinological, psychophysiological, psychometrically, neuropsychological measures are performed: just before the start of light therapy, after completion of three weeks therapy period, and three weeks thereafter.

Discussion: If BLT reduces nonseasonal depression in elderly patients, then additional lighting may easily be implemented in the homes of patients to serve as add-on treatment to antidepressants or as a stand-alone treatment in elderly depressed patients. In addition, if our data support the role of a dysfunctional biological clock in depressed elderly subjects, such a finding may guide further development of novel chronobiological oriented treatment strategies.

Trial registration: ClinicalTrials.gov identifier: NCT00332670.

Figures

Figure 1
Figure 1
Scheme-diagram of the trial protocol.

References

    1. Beekman ATF, Copeland JRM, Prince M. Review of community prevalence of depression in later life. British Journal of Psychiatry. 1999;174:307–311.
    1. Beekman AT, de Beurs E, van Balkom AJ, Deeg DJ, van DR, van Tilburg W. Anxiety and depression in later life: Co-occurrence and communality of risk factors. American Journal of Psychiatry. 2000;157:89–95.
    1. Beekman AT, Penninx BW, Deeg DJ, de Beurs E, Geerlings SW, van Tilburg W. The impact of depression on the well-being, disability and use of services in older adults: a longitudinal perspective. Acta Psychiatrica Scandinavica. 2002;105:20–7. doi: 10.1034/j.1600-0447.2002.10078.x.
    1. Penninx BWJH, Geerlings S, Deeg DJH, van Tilburg W, Beekman ATF. Minor and major depression and the risk of death in older persons. Archives of General Psychiatry. 1999;56:889–96. doi: 10.1001/archpsyc.56.10.889.
    1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet. 1997;349:1498–1504. doi: 10.1016/S0140-6736(96)07492-2.
    1. Buist-Bouwman MA, de Graaf R, Vollebergh WA, Alonso J, Bruffaerts R, Ormel J. Functional disability of mental disorders and comparison with physical disorders: a study among the general population of six European countries. Acta Psychiatrica Scandinavica. 2006;113:492–500. doi: 10.1111/j.1600-0447.2005.00684.x.
    1. Hoogendijk WJG, Van Someren EJW, Mirmiran M, Hofman MA, Lucassen PJ, Zhou JN, Swaab DJ. Structural hypothalamic changes in relation to circadian thythms and behavioural disturbances in Alzheimers' disease. International Psychogeriatrics. 1998;8:245–252.
    1. Deuschle M, Gotthardt U, Schweiger U, Weber B, Korner A, Schmider J, Standhardt H, Lammers CH, Heuser I. With aging in humans the activity of the hypothalamus-pituitary-adrenal system increases and its diurnal amplitude flattens. Life Science. 1997;61:2239–46. doi: 10.1016/S0024-3205(97)00926-0.
    1. Boiving DB. Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders. Journal of Psychiatry and Neuroscience. 2000;25:446–58.
    1. Bunney WE, Bunney BG. Molecular clock genes in man and lower animals: possible implications for circadian abnormalities in depression. Neuropsychopharmacology. 2000;22:335–45. doi: 10.1016/S0893-133X(99)00145-1.
    1. Grandin LD, Alloy LB, Abramson LY. The social zeitgeber theory, circadian rhythms, and mood disorders: Review and evaluation. Clinical Psychology Review. 2006;26:679–694. doi: 10.1016/j.cpr.2006.07.001.
    1. Rusting CL, Larsen RJ. Diurnal patterns of unpleasant mood: associations with neuroticism, depression, and anxiety. Journal of Personality. 1998;66:85–103. doi: 10.1111/1467-6494.00004.
    1. Booker JM, Hellekson CJ, Putilov AA, Danilenko KV. Seasonal depression and sleep disturbances in Alaska and Siberia: a pilot study. Arctic medical research. 1991:281–4.
    1. Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, Mueller PS, Newsome DA, Wehr TA. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Archives of General Psychiatry. 1984;41:72–80.
    1. Martiny K. Adjunctive bright light in non-seasonal major depression. Acta Psychiatrica Scandinavica. 2004;110:7–28. doi: 10.1111/j.1600-0447.2004.00460_2.x.
    1. Labbate LA, Lafer B, Thibault A, Sachs GS. Side-effects induced by bright light treatment for seasonal affective disorder. Journal of Clinical Psychiatry. 1994;55:189–191.
    1. Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, Suppes T, Wisner KL, Nemeroff CB. The Efficacy of Light Therapy in the Treatment of Mood Disorders : A Review and Meta-Analysis of the Evidence. American Journal of Psychiatry. 2005;162:656–662. doi: 10.1176/appi.ajp.162.4.656.
    1. Kripke DF. Light treatment for nonseasonal depression: speed, efficacy, and combined treatment. Journal of Affective Disorders. 1998;49:109–117. doi: 10.1016/S0165-0327(98)00005-6.
    1. Tuunainen A, Kripke DF, Endo T. The Cochrane Library. Chichester: John Wiley & Sons; 2004. Light therapy for nonseasonal depression (Cochrane Review)
    1. Even C, Schröder CM, Friedman S, Rouillon F. Efficacy of light therapy in nonseasonal depression: A systematic review. Journal of Affective Disorders. 2007
    1. Martiny K, Lunde M, Undén M, Dam H, Bech P. Adjunctive bright light in non-seasonal major depression: results from clinician-rated depression scales. Acta Psychiatrica Scandinaviva. 2005;112:117–25. doi: 10.1111/j.1600-0447.2005.00574.x.
    1. Martiny K, Lunde M, Undén M, Dam H, Bech P. Adjunctive bright light in non-seasonal major depression: results from patient-reported symptom and well-being scales. Acta Psychiatrica Scandinavica. 2005;111:453–9. doi: 10.1111/j.1600-0447.2005.00532.x.
    1. Goel N, Terman M, Terman JS, Macchi MM, Stewart JW. Controlled trial of bright light and negative air ions for chronic depression. Psychological Medicine. 2005;35:945–55. doi: 10.1017/S0033291705005027.
    1. Wirz-Justice A, Benedetti F, Berger M, Lam RW, Martiny K, Terman M, Wu JC. Chronotherapeutics (light and wake therapy) in affective disorders. Psychological Medicine. 2005;35:939–44. doi: 10.1017/S003329170500437X.
    1. Terman M. Evolving applications of light therapy. Sleep Medicine Reviews. 2007;11:497–507. doi: 10.1016/j.smrv.2007.06.003.
    1. Kim S, Song HH, Yoo SJ. The effect of bright light on sleep and behavior in dementia: an analytic review. Geriatric Nursing. 2003;24:239–243. doi: 10.1016/S0197-4572(03)00210-6.
    1. Forbes D, Morgan DG, Bangma J, Peacock S, Pelletier N, Adamson J. Light therapy for managing sleep, behavior, and mood disturbances in dementia. Cochrane Database Syst Rev. 2004;2:CD003946.
    1. Sumaya IC, Rienzi BM, Deegan JF, 2nd, Moss DE. Bright light treatment decreases depression in institutionalized older adults: a placebo-controlled crossover study. The journals of gerontology Series A, Biological sciences and medical sciences. 2001;56:M356–M360.55.
    1. Tsai YF, Wong TK, Juang YY, Tsai HH. The effects of light therapy on depressed elders. International Journal of Geriatric Psychiatry. 2004;19:545–548.56. doi: 10.1002/gps.1125.
    1. Loving RT, Kripke DF, Elliot JA, Knickerbocker NC, Grandner MA. Bright light treatment of depression for older adults [ISRCTN55452501] BMC Psychiatry. 2005
    1. Lewy AJ, Sack RL. Exogenous melatonin's phase-shifting effects on the endogenous melatonin profile in sighted humans: a brief review and critique of the literature. Journal of Biological Rhythms. 1997;12:588–94. doi: 10.1177/074873049701200614. Review.
    1. Foster RG, Helfrich-Förster C. The regulation of circadian clocks by light in fruitflies and mice. Philosophical transactions of the Royal Society of London Series B, Biological sciences. 2001;356:1779–89. doi: 10.1098/rstb.2001.0962.
    1. Brainard GC, Sherry D, Skwerer RG, Waxler M, Kelly K, Rosenthal NE. Effects of different wavelengths in seasonal affective disorder. Journal of Affective Disorders. 1990;20:209–16. doi: 10.1016/0165-0327(90)90052-A.
    1. Glickman G, Byrne B, Pineda C, Hauck WW, Brainard GC. Light therapy for seasonal affective disorder with blue narrow-band light-emitting diodes (LEDs) Biological Psychiatry. 2006;59:502–7. doi: 10.1016/j.biopsych.2005.07.006.
    1. Gallin PF, Terman M, Remé CE, Rafferty B, Terman JS, Burde RM. Ophthalmologic examination of patients with seasonal affective disorder, before and after bright light therapy. American Journal of Ophthalmology. 1995;119:202–10.
    1. Eastman CI, Young MA, Fogg LF, Liu L, Meaden PM. Bright light treatment of winter depression: a placebo-controlled trial. Archives of General Psychiatry. 1998;55:883–9. doi: 10.1001/archpsyc.55.10.883.
    1. Lewy AJ, Bauer VK, Cutler NL, Sack RL, Ahmed S, Thomas KH, Blood ML, Jackson JM. Morning vs evening light treatment of patients with winter depression. Archives of General Psychiatry. 1998;55:890–6. doi: 10.1001/archpsyc.55.10.890.
    1. Terman M, Terman JS, Ross DC. A controlled trial of timed bright light and negative air ionization for treatment of winter depression. Arcives of General Psychiatry. 1998;55:875–882. doi: 10.1001/archpsyc.55.10.875.
    1. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation of a geriatric depression screening scale: a preliminary report. Journal of Psychiatry Research. 1983;17:1982–37. doi: 10.1016/0022-3956(82)90033-4.
    1. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition 1995. New York State Psychiatric Institute : New York;
    1. Mackert A, Volz HP, Stieglitz RD, Müller-Oerlinghausen B. Phototherapy in nonseasonal depression. Biological Psychiatry. 1991;30:257–68. doi: 10.1016/0006-3223(91)90110-8.
    1. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2. Erlbaum, Hillsdale; 1988.
    1. World Medical Association Ethics Unit General Assembly, Declaration of Helsinki, the Edinburgh Amendment, Scotland. 2000.
    1. Montgomery SA, Äsberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry. 1979;134:382–389. doi: 10.1192/bjp.134.4.382.
    1. Williams JBW, Link MJ, Rosenthal NE, Amira L, Terman M. Structured Interview Guide for the Hamilton Rating Scale – Seasonal Affective Disorder version (SIGH-SAD) New York, New York State Psychiatric Institute; 1992.
    1. Hamilton M. Development of a rating scale for primary depressive illness. The British journal of social and clinical psychology. 1967;6:278–296.
    1. Kogan AO, Guilford PM. Side Effects of Short-Term 10,000-Lux Light Therapy. American Journal of Psychiatry. 1998;155:293–294.
    1. Van Someren EJW, Kessler A, Mirmiran M, Swaab DF. Indirect Bright Light Improves Circadian Rest-Activity Rhythms Disturbances in Demented Patients. Biological Psychiatry. 1997;41:955–963. doi: 10.1016/S0006-3223(97)89928-3.
    1. Hoekert M, Riemersma-Lek RF Van der, Swaab DF, Kaufer D, Van Someren EJW. Comparison between informant observed and actigraphic assessment of sleep-wake rhythm disturbances in demented residents of homes for the elderly. American Journal of Geriatric Psychiatry. 2006;14:104–11. doi: 10.1097/01.JGP.0000192481.27931.c5.
    1. Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Research. 1989;28:193–213. doi: 10.1016/0165-1781(89)90047-4.
    1. Monk TH, Flaherty JF, Frank E, Hoskinson K, Kupfer DJ. The social rhythm metric. An instrument to quantify the daily rhythms of life. The Journal of Nervous and Mental Disease. 1990;178:120–126. doi: 10.1097/00005053-199002000-00007.
    1. Monk TH, Frank E, Potts JM, Kupfer DJ. A simple way to measure daily lifestyle regularity. Journal of Sleep Research. 2002;11:183–190. doi: 10.1046/j.1365-2869.2002.00300.x.
    1. Van Sonderen E. Het meten van sociale steun met de Sociale Steun Lijst-Interacties (SSL-i) en Sociale Steun Lijst Discrepanties (SSL-d) : een handleiding/Eric van Sonderen. – Groningen 1993: Noordelijk Centrum voor Gezondheidsvraagstukken
    1. Kempen GIJM. The MOS Short-form General Health Survey: single item vs multiple measures of health related quality of life; some nuances. Psychological Reports. 1992;70:608–610. doi: 10.2466/PR0.70.2.608-610.
    1. Sherer M, Maddux JE, Mercadante B, Prentice-Dunn S, Jacobs B, Rogers RW. The self-efficacy scale: Construction and Validation. Psychological Reports. 1982;51:663–671.
    1. Lawton MP. The Philadelphia Geriatric Center Morale Scale: A Revision. J Gerontol. 1975;30:85–89.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner